期刊文献+

沙丁胺醇联合布地奈德雾化吸入治疗小儿哮喘的疗效 被引量:7

Efficacy of Salbutamol Combined with Budesonide Aerosol Inhalation in the Treatment of Asthma in Children
原文传递
导出
摘要 目的:探讨沙丁胺醇联合布地奈德雾化吸入治疗小儿哮喘的疗效。方法:选择2019年5月—2021年12月本院门诊诊治的哮喘患儿80例作为研究对象,按照随机数字表法分为联合组与布地奈德组,各40例。布地奈德组给予雾化吸入布地奈德治疗,联合组在布地奈德组治疗基础上给予沙丁胺醇雾化吸入治疗,比较两组症状消失时间、临床疗效、肺功能[第1秒用力呼气容积(FEV1)、呼气峰值流速(PEF)]、炎症因子[白介素-6(IL-6)、降钙素原(PCT)]表达变化情况。结果:联合组肺部哮鸣音消失时间、呼吸困难消失时间、咳嗽消失时间短于布地奈德组(P<0.05);联合组总有效率为97.5%,高于布地奈德组的80.0%(P<0.05);联合组FEV1、PEF水平高于布地奈德组(P<0.05);联合组IL-6、PCT水平低于布地奈德组(P<0.05)。结论:沙丁胺醇联合布地奈德雾化吸入治疗小儿哮喘的效果确切,可抑制IL-6、PCT的释放,改善肺功能,促进恢复临床症状。 Objective:To investigate the efficacy of salbutamol combined with budesonide aerosol inhalation in the treatment of pediatric asthma.Methods:A total of 80 children with asthma who were treated in our hospital from May 2019 to December 2021 were selected as the research subjects.According to the random number table method,they were divided into combined group and budesonide group,with 40 cases in each group.The budesonide group was treated with aerosol inhalation of budesonide,and the combined group was treated with aerosol inhalation of salbutamol on the basis of the treatment of budesonide group.The disappearance time of symptoms,clinical efficacy,pulmonary function [forced expiratory volume in one second(FEV1),peak expiratory flow(PEF)],inflammatory factors [interleukin-6(IL-6),procalcitonin(PCT)]were compared between the two groups.Results:The disappearance time of pulmonary wheeze,dyspnea and cough in the combined group were shorter than those in the budesonide group(P<0.05).The total effective rate of the combined group was 97.5%,which was higher than 80.0% of the budesonide group(P<0.05).FEV1 and PEF levels in the combined group were higher than those in the budesonide group(P<0.05).The levels of IL-6 and PCT in the combined group were lower than those in the budesonide group(P<0.05).Conclusion:Salbutamol combined with budesonide aerosol inhalation is effective in the treatment of asthma in children,which can inhibit the release of IL-6 and PCT,improve lung function and promote the recovery of clinical symptoms.
作者 李群飞 刘俊 LI Qunfei;LIU Jun(Department of Pediatric,Changshu No.2 People's Hospital,Changshu 215500,Jiangsu,China)
出处 《中国药物滥用防治杂志》 CAS 2022年第11期1624-1627,1632,共5页 Chinese Journal of Drug Abuse Prevention and Treatment
关键词 沙丁胺醇 布地奈德 雾化吸入 小儿哮喘 Salbutamol Budesonide Nebulized inhalation Asthma in children
  • 相关文献

参考文献11

二级参考文献85

  • 1Eun Lee,Young-Ho Kim,Seungbong Han,Song-I Yang,Young-Ho Jung,Ju-Hee Seo,Hyo-Bin Kim,So Yeon Lee,Ji-Won Kwon,Soo-Jong Hong.Different cutoff values of methacholine bronchial provocation test depending on age in children with asthma[J].World Journal of Pediatrics,2017,13(5):439-445. 被引量:1
  • 2代冰(综述),尚云晓(审校).长链非编码RNA的免疫调节机制及其在支气管哮喘中的研究进展[J].国际儿科学杂志,2018,45(12):911-915. 被引量:5
  • 3张景鸿,李超乾.支气管哮喘气道高反应性机制的研究进展[J].中国呼吸与危重监护杂志,2011,10(3):304-307. 被引量:21
  • 4Aiber MK. Skin Permeability: Dermatology aspect of Transdermal drug delivery[J]. Am Heart, 1984,10(8) :200.
  • 5Vyas S P. Development and characterization of Pseudolater based transdermal stag delivery system or diclofenal [ J ]. Drug Derlnd Pharm, 1991,17(7) :1041.
  • 6Morris M J,Madgwick R G,Collyer I,et al.Analysis of expiratory tidal flow patterns as a diagnostic tool in airflow obstruction[J].Eur Respir J,1998,12(5):1113-7.
  • 7Chavasse R J,Bastian-Lee Y,Richter H,et al.Inhaled salbutamol for wheezy infants:a randomized controlled trial[J].Arch Dis Child,2000,82(5):370-5.
  • 8Goldstein A B,Castile R G,Davis S D,et al.Bronchodilator resposiveness in normal infants and young children[J].Am J Respir Grit Med,2001,164(3):447-54.
  • 9Callaghan C O,Barry P W.The Sicence of nebulized drug delivery[J].Thorax,1997,52(2):31-44.
  • 10Atkinson TP,Duffy LB,Pendley D,et al.Deficient immuneresponse to Mycoplasma pneumoniae in childhood asthma[J].Allergy Asthma Proc,2009,30(2):158-165.

共引文献332

同被引文献93

引证文献7

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部